Search - tctmd.com

Displaying 101 - 120 of 4004

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk

Presenter: Marco Luciano Rossi

October 30, 2024

Presentation TCT 2024

TCT 1158: Type 3 Dissection After DCB: To Be or Not To Be Stent Implantation

Presenter: Afzalur Rahman

October 30, 2024

Presentation TCT 2024

TCT 1269: Ad Hoc Left Main Stem PCI Following Guide Catheter Dissection in a Patient With RCA CTO and Size Discrepancy: Benefits of a Modern DES With Hyperexpansile Capacity

Presenter: BASMA AHMAD

October 30, 2024

Presentation TCT 2024

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

Are Metallic Drug Eluting Stents As Good As it Gets?

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

A Hybrid Approach With Stents and Drug Coated Balloons: Mainstream or Niche?

Presenter: Ricardo Costa

October 30, 2024

Presentation TCT 2024

What I Learned From Successes and Failures in PCI with DCBs: A Case Parade

Presenter: Antonio Colombo

October 30, 2024

Presentation TCT 2024

Paclitaxel, Sirolimus, Biolimus: The Art of DCBs Selection

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

From ISR to De Novo Lesions: Keys to Success in Patient Selection for PCI With DCBs

Presenter: Sandeep Basavarajaiah

October 30, 2024

Presentation TCT 2024

A Primer in DCB Techniques: From Lesion Preparation to Drug Delivery and Bailout Stenting

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

Presenter: Olivier Bertrand

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Dealla Samadi

October 29, 2024

Presentation TCT 2024

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Presenter: Ikuta Akihiro

October 29, 2024

Presentation TCT 2024

TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound

Presenter: Takehiko Kido

October 29, 2024

Presentation TCT 2024

TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia

Presenter: Takehiko Kido

October 29, 2024

Presentation TCT 2024

TCT 1018: Plaque Risk Is Directly Related to the Type and Number of Combined Vulnerability Features: Insights From a Pooled Patient Level Analysis From COMBINE FFR_OCT and PECTUS-OBS Studies

Presenter: Elvin Kedhi

October 29, 2024

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

Advertisement

TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk

TCT 1158: Type 3 Dissection After DCB: To Be or Not To Be Stent Implantation

TCT 1269: Ad Hoc Left Main Stem PCI Following Guide Catheter Dissection in a Patient With RCA CTO and Size Discrepancy: Benefits of a Modern DES With Hyperexpansile Capacity

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Are Metallic Drug Eluting Stents As Good As it Gets?

A Hybrid Approach With Stents and Drug Coated Balloons: Mainstream or Niche?

What I Learned From Successes and Failures in PCI with DCBs: A Case Parade

Paclitaxel, Sirolimus, Biolimus: The Art of DCBs Selection

From ISR to De Novo Lesions: Keys to Success in Patient Selection for PCI With DCBs

A Primer in DCB Techniques: From Lesion Preparation to Drug Delivery and Bailout Stenting

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

TCT 501: Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

TCT 499: Predictors of Good Final Lumen Expansion After Treatment of Severe In-Stent Restenosis Neoatherosclerosis as Evaluated by Intravascular Ultrasound

TCT 498: Predictors of Larger Final Lumen Expansion After Treatment of In-Stent Restenosis With Fibrotic Neointimal Hyperplasia

TCT 1018: Plaque Risk Is Directly Related to the Type and Number of Combined Vulnerability Features: Insights From a Pooled Patient Level Analysis From COMBINE FFR_OCT and PECTUS-OBS Studies

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content